{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:48:20Z","timestamp":1773330500437,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ejmech.2017.05.013","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T06:35:43Z","timestamp":1493879743000},"page":"330-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Investigation of pyrazolo-sulfonamides as putative small molecule oxytocin receptor agonists"],"prefix":"10.1016","volume":"136","author":[{"given":"Timothy A.","family":"Katte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tristan A.","family":"Reekie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eryn L.","family":"Werry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William T.","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rochelle","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick C.N.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien W.","family":"Gulliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6655-0529","authenticated-orcid":false,"given":"Michael","family":"Kassiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.05.013_bib1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2174\/092986708783885291","article-title":"The role of oxytocin in neuropsychiatric disorders","volume":"15","author":"Marazziti","year":"2008","journal-title":"Curr.Med. Chem."},{"key":"10.1016\/j.ejmech.2017.05.013_bib2","series-title":"Progress in Brain Research","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0079-6123(08)00437-8","article-title":"Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents","author":"Manning","year":"2008"},{"key":"10.1016\/j.ejmech.2017.05.013_bib3","series-title":"Oxytocin Receptor Agonists for the Treatment of CNS Diseases","author":"Bissantz","year":"2014"},{"key":"10.1016\/j.ejmech.2017.05.013_bib4","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1021\/ml5004348","article-title":"Pyrazolsulfonamide agonists of oxytocin receptor","volume":"5","author":"Rosse","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.05.013_bib5","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1055\/s-0033-1338549","article-title":"Synthesis of biologically active seven-membered-ring heterocycles","volume":"45","author":"Reekie","year":"2013","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2017.05.013_bib6","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1016\/j.tetlet.2014.06.022","article-title":"Pyrazolo[1,4]diazepines as non-peptidic probes of the oxytocin and vasopressin receptors","volume":"55","author":"Reekie","year":"2014","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2017.05.013_bib7","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1021\/acs.joc.6b00710","article-title":"The formation of seven-membered heterocycles under mild Pictet\u2013spengler conditions: a route to Pyrazolo[3,4]benzodiazepines","volume":"81","author":"Katte","year":"2016","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2017.05.013_bib8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ejmech.2015.11.050","article-title":"Flexible analogues of WAY-267,464: synthesis and pharmacology at the human oxytocin and vasopressin 1a receptors","volume":"108","author":"Jorgensen","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.05.013_bib9","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1365-2826.2012.02311.x","article-title":"The nonpeptide oxytocin receptor agonist WAY 267,464: receptor-binding profile, prosocial effects and distribution of c-Fos expression in adolescent rats","volume":"24","author":"Hicks","year":"2012","journal-title":"J.\u00a0Neuroendocrinol."},{"key":"10.1016\/j.ejmech.2017.05.013_bib10","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s00213-015-3902-5","article-title":"WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action","volume":"232","author":"Hicks","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejmech.2017.05.013_bib11","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1111\/bph.12613","article-title":"Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats","volume":"171","author":"Hicks","year":"2014","journal-title":"Br. J. Pharmacol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417303744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417303744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T00:50:10Z","timestamp":1535849410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417303744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":11,"alternative-id":["S0223523417303744"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.05.013","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of pyrazolo-sulfonamides as putative small molecule oxytocin receptor agonists","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}